Pettersson Martin, Hou Xinjun, Kuhn Max, Wager Travis T, Kauffman Gregory W, Verhoest Patrick R
Worldwide Medicinal Chemistry, Pfizer Worldwide Research and Development , Cambridge, Massachusetts 02139, United States.
Research Statistics, Pfizer Worldwide Research and Development , Groton, Connecticut 06340, United States.
J Med Chem. 2016 Jun 9;59(11):5284-96. doi: 10.1021/acs.jmedchem.6b00027. Epub 2016 May 26.
Strategic replacement of one or more hydrogen atoms with fluorine atom(s) is a common tactic to improve potency at a given target and/or to modulate parameters such as metabolic stability and pKa. Molecular weight (MW) is a key parameter in design, and incorporation of fluorine is associated with a disproportionate increase in MW considering the van der Waals radius of fluorine versus hydrogen. Herein we examine a large compound data set to understand the effect of introducing fluorine on the risk of encountering P-glycoprotein mediated efflux (as measured by MDR efflux ratio), passive permeability, lipophilicity, and metabolic stability. Statistical modeling of the MDR ER data demonstrated that an increase in MW as a result of introducing fluorine atoms does not lead to higher risk of P-gp mediated efflux. Fluorine-corrected molecular weight (MWFC), where the molecular weight of fluorine has been subtracted, was found to be a more relevant descriptor.
用氟原子战略性地取代一个或多个氢原子是提高给定靶点活性和/或调节代谢稳定性和pKa等参数的常用策略。分子量(MW)是设计中的关键参数,考虑到氟与氢的范德华半径,引入氟会导致分子量不成比例地增加。在此,我们研究了一个大型化合物数据集,以了解引入氟对遭遇P-糖蛋白介导的外排风险(通过MDR外排率测量)、被动渗透性、亲脂性和代谢稳定性的影响。MDR ER数据的统计建模表明,引入氟原子导致的分子量增加不会导致P-糖蛋白介导的外排风险更高。发现减去氟分子量后的氟校正分子量(MWFC)是一个更相关的描述符。